US-based Prolacta Bioscience, best known for its human milk-based nutritional fortifiers, is conducting a clinical trial assessing the effect of its products on the growth of premature infants in Japan.
This round-up features new innovations in the Indian market with a focus on botanicals and plant-based ingredients to address liver, lung, cognitive health issues, rheumatoid arthritis, as well as the growth potential of the hemp industry.
There are a number of scientific reports which claim that there is a high rate of anaemia among the Indian population, but the latest guest of our NutraChampion podcast argues that this may not be the case and there may even be an “overdiagnosis” of anaemia...
Probiotics have boomed in China in recent years, accounting for almost half of Asia’s sales, but the nation’s infant nutrition market has begun slow, leading experts to call for more innovation and products with added functionality.
See our 10 most-read regulatory stories of 2021, including Recommended Dietary Allowance (RDA) policies in India, South Korea’s monitoring of krill oil and probiotics, and new standards for fish oil in Thailand.